Complex Generics: Pre-Competitive Research Collaborations To Get US FDA Funding Boost
Executive Summary
Center for Research on Complex Generics will be similar to the Critical Path Institute; training sessions for industry could begin in January.
You may also be interested in...
US Biosimilars Will Get Regulatory Science Program, Supplement Timeline Changes In Next User Fee Agreement
Talks are completed, leaving only the generic drug user fee reauthorization negotiations ongoing.
Biosimilars Will Get Regulatory Science Program, Supplement Timeline Changes In Next User Fee Agreement
Talks are completed, leaving only the generic drug user fee reauthorization negotiations ongoing.
US FDA Preparing For Potential Bolus Of Complex Generic Applications
Increasing number of product development meetings suggests that many complex generics remain in the development stages.